We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Mindray Displays New Generation Benchtop Cellular Analysis Line

By LabMedica International staff writers
Posted on 31 Jan 2019

Image: The CAL 6000 benchtop cellular analysis line (Photo courtesy of Mindray).

Image: The CAL 6000 benchtop cellular analysis line (Photo courtesy of Mindray).

Mindray (Shenzhen, China) exhibited its new generation benchtop cellular analysis line at MedLab Middle East, an international platform for laboratory management and medicine that brought together more than 700 exhibitors and over 35,000 professionals. MedLab Middle East 2019 took place at the Dubai International Convention and Exhibition Centre, Dubai, UAE from the 4th to the 7th of February.

Among Mindray’s latest innovations displayed at MedLab Middle East 2019 was CAL 6000, a benchtop cellular analysis line that connects two units of BC-6000 or BC-6200 auto hematology analyzers and one unit of SC-120 auto slide maker & stainer. The compact workstation helps save more laboratory space while delivering a fast throughput of up to 220 samples and 120 slides per hour. It provides automated body fluids test results, and is equipped with labXpert data management software for automatic sample validation and analysis.

At MedLab Middle East 2019, Mindray also exhibited the CL-900i chemiluminescence immunoassay analyzer, which has an industry-leading small benchtop footprint, a throughput of up to 180 tests per hour and 15 reagent positions. The CL-900i is a state-of-the-art system that is compact, fast and accurate, offering automation and reliable performance to ensure quality testing results with minimal hands-on time.

Visit expo >

Platinum Member

Automated Coagulation Analyzer

Hemolumi H6

βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®

Urine Analyzer

respons® UDS100

Gold Member

Blood-Based Protein Biomarker Solution for Alzheimer's Disease

BG-DTi2000.

Latest MEDLAB 2019 News

Channels

Clinical Chemistry

view channel

Image: A new study identified 17 plasma proteins linked to mortality in older adults, several of which also track biological ageing across multiple organ systems. (Image Credit: Adobe Stock)

Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems

Older adults of the same chronological age can differ markedly in health, chronic disease burden, and resilience. Biological age aims to capture these differences by reflecting how rapidly the body and... Read more

$Image: Distinct tau isoform signatures in Alzheimer\'s disease and amyotrophic lateral sclerosis. (Abu-Rumeileh, S., Großkopf, H., Guthknecht, A. et al. Nature Communications, 2026. DOI: 10.1038/s41467-026-78390-3)$

Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis

Early Alzheimer’s disease can be difficult to identify before more severe cognitive symptoms emerge. Blood tests measuring phosphorylated tau protein p-tau217 may help detect disease-related changes, but... Read more

Image Credit: Shutterstock

Common Kidney Function Tests May Miss CKD in Cancer Patients

Chronic kidney disease (CKD) can complicate cancer care, as reduced kidney filtration may affect treatment eligibility and dosing. In oncology, kidney function assessment often relies on estimated glomerular... Read more

Image Credit: Adobe Stock

Point-of-Care Blood Biomarker Test Detects Brain Injury Missed by CT

Traumatic brain injury remains difficult to assess in emergency settings because some patients continue to have symptoms despite normal computed tomography findings. Approximately 2.8 million people in the U.... Read more

Molecular Diagnostics

view channel

Tumor and Immune Biomarkers Linked to Treatment Response in T-Cell Lymphoma

T-follicular helper cell lymphoma (TFHL) is a subtype of peripheral T-cell lymphoma associated with poor prognosis and limited treatment options after relapse. Its molecular abnormalities include frequent... Read more

Blood MRD Testing Aids Risk Analysis in Bladder and Other Cancers

Natera (Austin, TX, USA) presented findings from 25 abstracts, including nine oral presentations, at the ESMO Congress 2026 in Madrid. The research examined circulating tumor DNA (ctDNA) testing for molecular... Read more

Image: Researchers demonstrated a liquid biopsy approach that can measure cancer burden and characterize SCLC from blood (Image Credit: iStock)

Liquid Biopsy Measures Tumor Burden and Identifies Small Cell Lung Cancer Subtypes

Small cell lung cancer (SCLC) accounts for roughly 15% of lung cancer cases and is characterized by rapid growth, early spread, and poor survival outcomes. Although scientists have identified molecular... Read more

Rapid Lab-Free UTI Test Enters First Use in Care Home Setting

Urinary tract infections (UTIs) frequently lead to hospital admission and antibiotic use among older residents of UK care homes. Diagnosis can be challenging when classic urinary symptoms are absent, particularly... Read more

Hematology

view channel

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis

Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more

Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma

Severe blood loss and inadequate tissue oxygenation are leading causes of preventable death after traumatic injury. Blood products are essential in trauma care, but cold-chain storage, short shelf life,... Read more

Immunology

view channel

Prototype Point-of-Care Lateral Flow Test Aims to Improve Neonatal Sepsis Triage

Sepsis in newborns and young infants remains a major clinical challenge, particularly in low- and middle-income countries. An estimated 2.3 million newborns die each year, with sepsis contributing substantially... Read more

Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk

Cytokine release syndrome (CRS) can occur after chimeric antigen receptor (CAR) T-cell therapy in patients with autoimmune disease. Identifying which patients are more likely to develop this complication... Read more

COVID-19 and Flu Combo Test Launches With FDA Clearance

Overlapping symptoms of COVID-19 and influenza can create diagnostic uncertainty, particularly in urgent and point-of-care settings. Rapid differentiation from a single specimen can streamline triage and... Read more

Compact Immunoanalyzer Gains CE Mark for Testing Across Local Care Settings

Smaller clinics and laboratories must deliver reliable results despite limited infrastructure, outsourcing delays, and workforce shortages. These pressures highlight the need for consistent immunoassay... Read more

Microbiology

view channel

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response

The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read more

Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis

Sepsis and severe infections are difficult to treat because patients with similar clinical presentations may have very different underlying immune responses. Corticosteroids are commonly used in severe... Read more

Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms

Long Covid can involve persistent respiratory, cognitive, and gastrointestinal symptoms after acute infection, creating a difficult diagnostic and management challenge. Because COVID-19 initially affects... Read more

Pathology

view channel

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more

Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis

Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

$Image: Ovarian cancer tissue image. (Photo courtesy of Heba Sailem/King\'s College London)$

AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer

High-grade serous tubo-ovarian carcinoma is an aggressive cancer arising in the ovaries or fallopian tubes. Some tumors exhibit homologous recombination deficiency (HRD), a feature reflecting impaired DNA repair.... Read more

Technology

view channel

Image: Device schematic and experimental workflow (Williams, E.K., Zhang, D.Y., Alese, T.T. et al. Nature Biomedical Engineering, 2026. https://doi.org/10.1038/s41551-026-01818-0)

Microfluidic Assay Predicts Treatment Response in Pediatric Leukemia

Acute lymphoblastic leukemia (ALL) is a rapidly developing blood cancer that can disrupt production of mature infection-fighting white blood cells within months. More than 120,000 people in the U.... Read more

Image Credit: Adobe Stock

AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk

Cancer screening programs cover only certain cancers and often rely on broad eligibility criteria, limiting individualized risk assessment across multiple cancer types. Routine health data, including blood... Read more

Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows

Molecular laboratories rely on nucleic acid analysis to detect molecular information accurately and reproducibly across a wide range of applications. Supporting these routine workflows, a newly launched... Read more

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel

CE-Marked IVD Sequencing Platform Launches Across Ten EU Countries

Clinical laboratories using sequencing in regulated diagnostic workflows need systems that support clearly defined processes and documentation. In Europe, meeting applicable EU IVDR requirements also means... Read more

Collaboration Brings Tumor-Informed MRD Monitoring to Breast Cancer Care in Abu Dhabi

For many patients, cancer treatment does not eliminate the risk of recurrence, which may occur months or years later and become harder to treat after spreading. Recurrence is often detected only after... Read more

Real Diagnostics Adds Saliva-Based Periodontal Testing With SimplyTest Deal

Real Diagnostics (Reisterstown, MD, USA) has acquired SimplyTest (Huntsville, AL, USA), a provider of saliva-based diagnostic tests for oral health. The acquisition adds the SimplyTest PERIO product to... Read more

Qiagen Agrees to Go Private Through EQT-Led Acquisition

QIAGEN N.V. (Venlo, the Netherlands) and EQT Private Equity (Stockholm, Sweden) have agreed to an all-cash public takeover offer for all outstanding QIAGEN shares at EUR 46.50 per share.... Read more